No Data
No Data
Hima Medical (03309.HK) received an increase in shareholding of 1.004 million shares from Chairman, CEO and Executive Director Lin Shunchao.
According to the latest equity disclosure information from the Hong Kong Stock Exchange, from September 12th to September 16th, 2024, Xima Medical (03309.HK) chairman, CEO and executive director Lin Shunchao purchased a total of 1.004 million shares at an average price of HK$2.0308-2.0571 per share, with a total investment of approximately HK$2.05 million. After the shareholding, Lin Shunchao's latest shareholding is 691,616,553 shares, and the shareholding ratio has increased from 55.00% to 55.08%.
Shares of Xima Medical (03309) fell 39.00%, now trading at HKD 1.820, hitting a 52-week low.
As of 11:46, Xima Medical (03309) has dropped 39.00% compared to the previous closing price, currently at 1.820 yuan, hitting a new 52-week low; the volume of trade is 0.538 million shares, with a turnover of 0.9845 million Hong Kong dollars.
Healthcare company Sima Medical (03309) plans to use up to 0.1 billion Hong Kong dollars of cash to repurchase shares in the market.
Himax Medical (03309) has announced that the board of directors has been closely monitoring the recent stock price of the company and making decisions based on the 202...
Express News | C-Mer Eye Care - Apply up to HK$100 Mln of Its Cash to Repurchase Shares
It's Down 27% But C-MER Medical Holdings Limited (HKG:3309) Could Be Riskier Than It Looks
Returns On Capital At C-MER Medical Holdings (HKG:3309) Paint A Concerning Picture
No Data
No Data